Our study aims to investigate the miRNA-101 differential expression in Egyptian HCV-induced HCC patients’ serum versus HCV liver cirrhosis (LC) as prospective diagnostic biomarkers compared to alpha-fetoprotein (AFP). Here, AFP is linked to hepatocellular carcinoma.